We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Axon Instruments and Aviva Biosciences Screening Collaboration
News

Axon Instruments and Aviva Biosciences Screening Collaboration

Axon Instruments and Aviva Biosciences Screening Collaboration
News

Axon Instruments and Aviva Biosciences Screening Collaboration

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Axon Instruments and Aviva Biosciences Screening Collaboration"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Axon Instruments, Inc. and Aviva Biosciences Corp. announced an exclusive agreement to collaborate on the development and commercialization of a Patch-on-a-Chip™ planar electrode device for use in Axon's PatchXpress ion channel drug screening systems. The agreement gives Axon exclusive marketing rights to Aviva's patch-clamp biochip. The first PatchXpress systems will be available for customer testing by the end of the third quarter in 2002, with release to production anticipated by the end of the year.
Advertisement